Interpretation of the 2022 American Academy of Pediatrics guidelines for the management of hyperbilirubinemia in newborn infants / 中国当代儿科杂志
Chinese Journal of Contemporary Pediatrics
; (12): 11-17, 2023.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-971033
Biblioteca responsável:
WPRO
ABSTRACT
The American Academy of Pediatrics updated the guidelines for the management of hyperbilirubinemia in the newborn infants with a gestational age of ≥35 weeks in September 2022. Based on the evidence over the past 18 years, the guidelines are updated from the aspects of the prevention, risk assessment, intervention, and follow-up of hyperbilirubinemia in the newborn infants with a gestational age of ≥35 weeks. This article gives an interpretation of the key points in the guidelines, so as to safely reduce the risk of bilirubin encephalopathy and unnecessary intervention.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Estados Unidos
/
Bilirrubina
/
Idade Gestacional
/
Medição de Risco
/
Hiperbilirrubinemia Neonatal
/
Hiperbilirrubinemia
/
Kernicterus
Limite:
Criança
/
Humanos
/
Lactente
/
Recém-Nascido
País/Região como assunto:
América do Norte
Idioma:
Chinês
Revista:
Chinese Journal of Contemporary Pediatrics
Ano de publicação:
2023
Tipo de documento:
Artigo